Bangkok, March 3, 2015 ? The SEC organized ?1st SEC Working Papers Forum, 2015? where the Faculty of Commerce and Accountancy, Chulalongkorn University presented research papers on ?Impacts of
Thai Capital Market and Economic Growth.” In addition, the research team from Thammasat University led by Prof. Witawat Rungruangphon and Mr. Weerapong Kitiwong, PhD., presented the results of the Value
. And revenue from new dialysis center has tend of income as increase continuously which it can reduce the gap of ongoing costs. This has resulted, the gross margins as increase from the previous year
Laboratory and Research Center (“AMARC”). Costs and Expenses The Company reported the consolidated costs and expenses for Q1/2019 of Baht 345.54 million, nearby of Q1/2018 of Baht 345.61 million decreased by
booked in year 2018 for chronic diseases were then subtracted accordingly. However, the service revenues (mainly received from Asia Medical and Agricultural Laboratory and Research Center Co., Ltd “AMARC
to the hospital. In regard to the subsidiary, Asia Medical & Agricultural Laboratory and Research Center (“AMARC”), its service revenues grew by 12.60% as it provides laboratory testing and analyzing
until July 31, 2014.The Project was launched to raise awareness and accessibility to capital market among business operators in areas of research, development, science, technology and innovation as well
rate risk gap report for monitoring interest rate risk and assessing net interest income sensitivity over the next 12 months, based on an assumption of a 1.00-percent change in interest rates on all
company paid maintenance software ,Research and development. 1.5 In Q3-2017, Management's Remuneration increase amount 4 Million Baht equivalent 30% from previous year because the company restructuring
% due to Training & Education. 1.5 Administrative expenses increased 9.14 MB or 6.49 % due to develop manpower by Training, Product Research and Development and Warehouse Management. 1.6 Corporate income